Form 8-K - Current report:
SEC Accession No. 0001683168-22-005083
Filing Date
2022-07-22
Accepted
2022-07-22 16:28:43
Documents
14
Period of Report
2022-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT snoa_i8k.htm   iXBRL 8-K 33082
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND AMY TRO snoa_ex1001.htm EX-10.1 138129
3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND BRUCE T snoa_ex1002.htm EX-10.2 149713
  Complete submission text file 0001683168-22-005083.txt   566864

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20220722.xsd EX-101.SCH 2971
5 XBRL LABEL FILE snoa-20220722_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snoa-20220722_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT snoa_i8k_htm.xml XML 3583
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 221100207
SIC: 2834 Pharmaceutical Preparations